| GO Type |
GO Category |
Enriched GO Terms |
p-Value |
Adjusted p-Value |
Enriched Genes |
| BP |
GO:0009987; cellular process
|
GO:0000733; DNA strand renaturation |
1.863E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0008152; metabolic process
|
GO:0051974; negative regulation of telomerase activity |
2.069E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0006983; ER overload response |
2.276E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0090399; replicative senescence |
2.483E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0032501; multicellular organismal process
|
GO:0008340; determination of adult lifespan |
2.483E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0051179; localization
|
GO:1901386; negative regulation of voltage-gated calcium channel activity |
3.516E-03 |
1.000E+00 |
GPR35 |
| BP |
GO:0050896; response to stimulus
|
GO:0010224; response to UV-B |
3.723E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0031000; response to caffeine |
3.723E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0043153; entrainment of circadian clock by photoperiod |
3.929E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0055093; response to hyperoxia |
4.342E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0048511; rhythmic process
|
GO:0048512; circadian behavior |
4.342E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0008152; metabolic process
|
GO:1902895; positive regulation of pri-miRNA transcription from RNA polymerase II promoter |
4.548E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0032461; positive regulation of protein oligomerization |
4.755E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0008152; metabolic process
|
GO:0009299; mRNA transcription |
5.167E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0071480; cellular response to gamma radiation |
5.580E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0006284; base-excision repair |
6.198E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0008283; cell proliferation
|
GO:0048147; negative regulation of fibroblast proliferation |
6.611E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0010165; response to X-ray |
6.817E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0042149; cellular response to glucose starvation |
7.641E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0034605; cellular response to heat |
9.287E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0043525; positive regulation of neuron apoptotic process |
9.904E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0008283; cell proliferation
|
GO:0048662; negative regulation of smooth muscle cell proliferation |
9.904E-03 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:2001244; positive regulation of intrinsic apoptotic signaling pathway |
1.155E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0006977; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
1.278E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0051289; protein homotetramerization |
1.524E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0042060; wound healing |
1.585E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0008152; metabolic process
|
GO:2000379; positive regulation of reactive oxygen species metabolic process |
1.851E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0065007; biological regulation
|
GO:0051453; regulation of intracellular pH |
1.871E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0071456; cellular response to hypoxia |
2.136E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0034614; cellular response to reactive oxygen species |
2.218E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0050896; response to stimulus
|
GO:0045471; response to ethanol |
2.381E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0097237; cellular response to toxic substance |
2.462E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:0030308; negative regulation of cell growth |
3.252E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0008152; metabolic process
|
GO:0050731; positive regulation of peptidyl-tyrosine phosphorylation |
3.535E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:1901796; regulation of signal transduction by p53 class mediator |
3.595E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0009987; cellular process
|
GO:1902749; regulation of cell cycle G2/M phase transition |
4.399E-02 |
1.000E+00 |
TP53 |
| BP |
GO:0008152; metabolic process
|
GO:0006914; autophagy |
4.459E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0097371; MDM2/MDM4 family protein binding |
1.449E-03 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0035035; histone acetyltransferase binding |
5.580E-03 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0051721; protein phosphatase 2A binding |
5.786E-03 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0001221; transcription cofactor binding |
7.641E-03 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0043621; protein self-association |
1.114E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0030971; receptor tyrosine kinase binding |
1.155E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0003684; damaged DNA binding |
1.380E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0002039; p53 binding |
1.442E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0042826; histone deacetylase binding |
2.218E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0001046; core promoter sequence-specific DNA binding |
2.299E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0001085; RNA polymerase II transcription factor binding |
2.381E-02 |
1.000E+00 |
TP53 |
| MF |
GO:0005488; binding
|
GO:0005524; ATP binding |
3.159E-02 |
1.000E+00 |
EIF4A1, TP53 |
